To improve the efficiency of Cervical Cancer Screening in Georgia (validation of Study Questionnaire)

Gvantsa Guliashvili, Tamar Alibegashvili



Background: Cervical cancer has one of the highest mortality rates in the world, as well as in Georgia.
Aim: The study objective was to investigate the pilot group in order to validate questionnaire developed by us. 
Methods: 61 women aged 16-74 (mean age-31.10+13.53) participated in the pilot survey. They were asked to fill in (answer)  questionnaire created by the above method:The questionnaire included the following factors: Age; Ethnicity; Religion; Marital status; At what age did you get married for the first time? How many kids do you have? What is your education? Where do you work? What do you know about cervical cancer? From where did you hear about cervical cancer? How do you think, what are the reasons for developing cervical cancer and contributing factors? Symptoms of cervical cancer? Do you have information? Lack of resources? Doctor-related barriers; I think that it is not necessary, because; Psychosocial factors; Fear of screening/test results; Fear of procedure; If you have been screened; How many screening rounds have you visited. We assessed the validity of the questionnaire using Cronbach's alpha. Concordance between questions is reliable when a>0.70.

Results: The questionnaire turned out to be clear for doctors, nurses. Another portion of responders needed help with the wording and content of the question. Testing questionnaire for concordance revealed that Cronbach's Alpha=0.719. which shows the high correlation between factors.

Conclusion: questionnaire has been developed, which is valid for finding ways to improve cervical cancer for questionnaire survey of the medical community and target population of screening.


Cervical cancer; Questionnaire; Screening.

Full Text:



Healthcare, Statistical Reference Georgia 2019

Hartwig S, Baldauf JJ, Dominiak-Felden G, Simondon F, Alemany L, de Sanjosé S, Castellsagué X. Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines. Papillomavirus Res. 2015 Dec 1;1:90-100.

Paz-Zulueta M, Álvarez-Paredes L, Díaz JC, Parás-Bravo P, Becerra ME, Ingelmo JM, García MM, Portilla J, Santibañez M. Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions. BMC cancer. 2018 Dec;18(1):1-9.

Centers for Disease Control and Prevention. Genital HPV infection fact sheet. Rockville: MD: CDC National Prevention Information Network. 2014 Jan 23.

Draft WH. Global Strategy Towards Eliminating Cervical Cancer as a Public Health Problem. WHO: Geneva, Switzerland. 2019 Dec.

Cutts FT, Franceschi S, Goldie S, Castellsague XD, De Sanjose S, Garnett G, Edmunds WJ, Claeys P, Goldenthal KL, Harper DM, Markowitz L. Human papillomavirus and HPV vaccines: a review. Bulletin of the World Health Organization. 2007;85:719-26.

García-Perdomo HA, Osorio JC, Fernandez A, Zapata-Copete JA, Castillo A. The effectiveness of vaccination to prevent the papillomavirus infection: a systematic review and meta-analysis. Epidemiol Infect. 2019 Jan;147

Liu T, Li S, Ratcliffe J, Chen G. Assessing knowledge and attitudes towards cervical cancer screening among rural women in Eastern China. Int J Environ Res Public Health. 2017:14(9), 967.

Donatus L, Nina FK, Sama DJ, Nkfusai CN, Bede F, Shirinde J, Cumber SN. Assessing the uptake of cervical cancer screening among women aged 25-65 years in Kumbo West Health District, Cameroon. Pan Afr Med J, 2019: 33.

Kivistik A, Lang K, Baili P, Anttila A, Veerus P. Women's knowledge about cervical cancer risk factors, screening, and reasons for non-participation in cervical cancer screening programme in Estonia. BMC women's health. 2011 Dec;11(1):1-6.

Oluwole EO, Mohammed AS, Akinyinka MR, Salako O. Cervical cancer awareness and screening uptake among rural women in Lagos, Nigeria. Journal of Community Medicine and Primary Health Care. 2017;29(1):81-8.

Ertem G. Awareness of cervical cancer risk factors and screening behaviour among nurses in a rural region of Turkey. Asian Pac J Cancer Prev. 2009 Jan 1;10(5):735-8.

Ertem G. Awareness of cervical cancer risk factors and screening behaviour among nurses in a rural region of Turkey. Asian Pac J Cancer Prev. 2009 Jan 1;10(5):735-8.


  • There are currently no refbacks.


Become a REVIEWER 


ISSN: 2346-8491 (online)